Sign in

You're signed outSign in or to get full access.

Karen A. Morrison

Director at GREIFGREIF
Board

About Karen A. Morrison

Karen A. Morrison, age 65, is an independent director of Greif, Inc. (GEF); she joined the board in 2022 and has served as an independent director since 2023. She is President of the OhioHealth Foundation and Senior Vice President of External Affairs at OhioHealth, where she has held leadership roles since 1988, bringing governance, finance, compliance, and healthcare expertise to the board. She serves on GEF’s Audit Committee and is considered independent under NYSE rules.

Past Roles

OrganizationRoleTenureCommittees/Impact
OhioHealth FoundationPresident; SVP External Affairs, OhioHealthSince 2008; roles at OhioHealth since 1988Governance, government affairs, auditing, finance, ethics & compliance, strategic planning, M&A experience
SafeAuto Financial CorporationBoard member (past)Not disclosedExternal market/financial exposure
Fifth Third Bank – Central Ohio Affiliate (Advisory Board)Advisory board member (past)Not disclosedFinancial services insight
Columbus Zoo and AquariumBoard member (past)Not disclosedCommunity engagement, oversight
Columbus Board of HealthBoard member (past)Not disclosedPublic health governance
Ohio University Heritage College of Osteopathic MedicineBoard member (past)Not disclosedAcademic/healthcare governance

External Roles

OrganizationRoleStatus
Park National Bank (NYSE)Board memberCurrent
Palmer-Donavin Manufacturing CompanyBoard memberCurrent
Columbus Regional Airport AuthorityBoard memberCurrent

Board Governance

  • Committee assignments: Audit Committee member; the Audit Committee met 5 times in fiscal 2024 and oversees financial reporting, internal controls, ERM and approves related-party transactions.
  • Attendance and engagement: The Board held five meetings in fiscal 2024; all incumbent directors attended ≥75% of Board and committee meetings, and all directors nominated attended the 2024 virtual annual meeting.
  • Independence: The Board determined all current directors are independent except the CEO; Morrison is independent under NYSE rules.

Fixed Compensation

Component (FY 2024)Amount (USD)
Cash Fees$111,307
Equity (Restricted Shares fair value)$141,943
Total$253,250
Director Fee Schedule (Policy)Amount (USD)
Annual cash retainer – outside director$100,000
Annual equity award – outside director~$142,000
Audit Committee member retainer$10,000
Compensation Committee member retainer$10,000
Nominating Committee member retainer$5,000
Audit Committee chair retainer$20,000
Compensation Committee chair retainer$20,000
Nominating Committee chair retainer$15,000

Notes:

  • Directors may defer cash fees and restricted stock under the Directors Deferred Compensation Plan. Deferrals of restricted stock are held in a rabbi trust; cash deferrals are credited as “Phantom Shares.”

Performance Compensation

Director Equity Grant Details (FY 2024)Value
Restricted shares granted (outside directors at 2024 annual meeting)2,247 shares
Grant fair value (based on $63.17 close on 2/23/2024)~$141,943
Vesting/transferFully vested at grant; subject to transfer restrictions for 3 years; eligible for dividends

There are no performance-based equity awards (e.g., PSUs) or options for outside directors in fiscal 2024; awards are time-based restricted shares only.

Other Directorships & Interlocks

CompanyNaturePotential Interlock/Conflict Considerations
Park National Bank (NYSE)Financial institutionNo GEF transactions disclosed; board independence affirmed broadly (not specific to Park National).
Palmer-Donavin Manufacturing CompanyPrivate manufacturing/distributionNo GEF transactions disclosed.
Columbus Regional Airport AuthorityPublic authorityNo GEF transactions disclosed.

Related-party/affiliation note: In fiscal 2022 GEF donated $25,000 to OhioHealth (Morrison’s employer); the Board determined this would not impact her independence.

Expertise & Qualifications

  • Governance/Board service; government affairs; auditing and finance; ethics and compliance; healthcare; strategic planning; M&A.
  • Board skills framework highlights Healthcare, Governance/Board Service, Accounting/Finance, Risk Management—areas aligned with Morrison’s background.

Equity Ownership

SecurityBeneficially OwnedNotes
Class A Common Stock9,201 shares
Restricted Class A shares (subject to transfer restrictions)6,732 shares (as of 10/31/2024)
Deferred restricted shares in rabbi trust2,016 shares (as of 12/27/2024)
  • Stock ownership guidelines: Outside directors must hold ≥5x annual retainer within five years; all outside directors are currently in compliance.

Governance Assessment

  • Board effectiveness: Active Audit Committee participation; committee remit includes related-party review—a key governance safeguard.
  • Independence: Affirmed by the Board; prior OhioHealth donation deemed immaterial to independence.
  • Attendance: Meets expectations (≥75% threshold across Board/committee service; full annual meeting attendance by nominees).
  • Alignment: Meaningful equity component (~$142k restricted stock annually with 3-year transfer restrictions) and stock ownership guidelines enhance alignment; ability to defer into rabbi trust indicates long-term orientation.
  • Compensation structure: No options, no performance-based director equity; compensation is standard market retainer-plus-equity for outside directors; no meeting fees.
  • Potential conflicts: Historical donation to OhioHealth disclosed; Board assessed and maintained independence; no related-party transactions disclosed for Morrison in FY2024–FY2025 proxy beyond this historical note.
  • Risk indicators: No Section 16 filing delinquencies reported for Morrison in FY2024; hedging/pledging restrictions apply company-wide, and pledge disclosures in holdings table do not identify Morrison.

RED FLAGS: None disclosed specific to Morrison (no low attendance, no related-party transactions in FY2024, no pledging noted). Historical OhioHealth donation was small and explicitly ruled not independence-impairing by the Board.